References
Lion C, Escande F, Burdin JC (1996) Capnocytophaga canimorsus infections in human: review of the literature and cases report. Eur J Epidemiol 12:521–533
Kullberg BJ, Westendorp RGJ, van’t Wout JW, Meinders AE (1991) Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerlyDF-2) septicaemia complication of dog bite. Medicine (Baltimore) 70:287–292
Rintala E, Kauppila M, Seppälä O-P, Voipio-Pulkki L-M, Pettilä V, Rasi V, Kotilainen P (2000) Protein C substitution in sepsis associated purpura fulminans. Crit Care Med 28:2373–2378
Bernard GR, Vicent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez AS, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709
Zenz W (1995) Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator. Thromb Haemost 74:802–803
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van de Ven, A.R.T., van Vliet, A.C.M., Maraha, B. et al. Fibrinolytic therapy in Capnocytophaga canimorsus sepsis after dog bite. Intensive Care Med 30, 1980 (2004). https://doi.org/10.1007/s00134-004-2387-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-004-2387-1